{"id":5018,"date":"2022-10-26T12:16:20","date_gmt":"2022-10-26T16:16:20","guid":{"rendered":"https:\/\/med.virginia.edu\/cphg\/?p=5018"},"modified":"2026-05-22T16:24:25","modified_gmt":"2026-05-22T20:24:25","slug":"cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments","status":"publish","type":"post","link":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/","title":{"rendered":"CPHG&#8217;s Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments"},"content":{"rendered":"<div class=\"entry-content\">\n<div id=\"attachment_8805\" class=\"wp-caption alignright\">\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-8805 size-thumbnail\" src=\"https:\/\/news.med.virginia.edu\/files\/2022\/10\/Naegle-Preferred_200x200-1-200x200.jpg\" alt=\"Kristen Naegle, PhD\" width=\"200\" height=\"200\" aria-describedby=\"caption-attachment-8805\" \/><\/p>\n<p id=\"caption-attachment-8805\" class=\"wp-caption-text\">Kristen Naegle, PhD<\/p>\n<\/div>\n<p>UVA Cancer Center researchers have developed an algorithm that will\u00a0<strong>improve cancer care<\/strong>\u00a0by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors. The algorithm may have other diagnostic benefits for patients as well.<\/p>\n<p>Kinase inhibitors are the most common cancer drugs approved by the federal Food and Drug Administration. They can be hugely effective for the right patients, but they don\u2019t work for everyone. UVA\u2019s new algorithm offers a new and better way to pinpoint patients who will benefit \u2013 an important step forward in precision medicine tailored to the individual.<\/p>\n<p>\u201cWe are really excited about this algorithm, which performs better than existing approaches with fewer requirements and assumptions \u2013 making it more applicable to understanding a cancer state from a single snapshot of the tumor.\u201d \u00a0said researcher Kristen M. Naegle, PhD, of UVA\u2019s Department of Biomedical Engineering, a joint program of UVA\u2019s School of Medicine and School of Engineering. \u201cCombining this approach with existing biomarkers for cancer diagnosis may help us to better tailor therapies, design new combination therapies, anticipate response to treatment and design better clinical trials.\u201d<\/p>\n<p><strong>KSTAR for Better Cancer Care<\/strong><\/p>\n<p>Naegle and colleagues set out to overcome the limitations of existing methods to identify patients who may benefit from kinase inhibitors. Most of these methods require difficult-to-obtain and sometimes unreliable information quantifying \u201cphosphorylation sites\u201d within cells. UVA\u2019s new approach, however, does not need all this complex measurement. Instead, it can \u201cinfer,\u201d or predict, key information based on other available data. This allows the algorithm to produce a specific \u201cKSTAR score\u201d for individual enzymes called kinases. Doctors can use these scores to determine which patients will respond to kinase inhibitors, helping guide the best treatment choices.<\/p>\n<p>In testing their new algorithm, Naegle and her collaborators found that it worked reliably across different tissue types, suggesting it is useful for many types of cancer. (Kinase inhibitors are widely used for certain types of blood, breast and lung cancers, among others. These drugs are often used in conjunction with other treatments, such as chemotherapy, radiation or surgery.)<\/p>\n<p><a href=\"https:\/\/news.med.virginia.edu\/research\/kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/?j=2102638&amp;sfmc_sub=7202895&amp;l=834_HTML&amp;u=33887888&amp;mid=100026982&amp;jb=5\">Continue to full Article here<\/a>.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kristen Naegle, PhD UVA Cancer Center researchers have developed an algorithm that will\u00a0improve cancer care\u00a0by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors. The algorithm may have other diagnostic benefits for patients as well. Kinase inhibitors are the most common cancer drugs approved by the federal Food and [&hellip;]<\/p>\n","protected":false},"author":1287,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[3,8,1],"tags":[15,196,113],"class_list":["post-5018","post","type-post","status-publish","format-standard","hentry","category-homepage-feed","category-people","category-uncategorized","tag-cphg","tag-intranet","tag-kristen-naegle"],"acf":false,"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CPHG&#039;s Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments - Department of Genome Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CPHG&#039;s Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments - Department of Genome Sciences\" \/>\n<meta property=\"og:description\" content=\"Kristen Naegle, PhD UVA Cancer Center researchers have developed an algorithm that will\u00a0improve cancer care\u00a0by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors. The algorithm may have other diagnostic benefits for patients as well. Kinase inhibitors are the most common cancer drugs approved by the federal Food and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Genome Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-26T16:16:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-22T20:24:25+00:00\" \/>\n<meta name=\"author\" content=\"jmd9fe@virginia.edu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jmd9fe@virginia.edu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/\"},\"author\":{\"name\":\"jmd9fe@virginia.edu\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/#\\\/schema\\\/person\\\/15282b0b67e8539d94e9d2e87eceacc9\"},\"headline\":\"CPHG&#8217;s Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments\",\"datePublished\":\"2022-10-26T16:16:20+00:00\",\"dateModified\":\"2026-05-22T20:24:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/\"},\"wordCount\":370,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/news.med.virginia.edu\\\/files\\\/2022\\\/10\\\/Naegle-Preferred_200x200-1-200x200.jpg\",\"keywords\":[\"CPHG\",\"Intranet\",\"Kristen Naegle\"],\"articleSection\":[\"Homepage Feed\",\"People\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/\",\"name\":\"CPHG's Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments - Department of Genome Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/news.med.virginia.edu\\\/files\\\/2022\\\/10\\\/Naegle-Preferred_200x200-1-200x200.jpg\",\"datePublished\":\"2022-10-26T16:16:20+00:00\",\"dateModified\":\"2026-05-22T20:24:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/#\\\/schema\\\/person\\\/15282b0b67e8539d94e9d2e87eceacc9\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/news.med.virginia.edu\\\/files\\\/2022\\\/10\\\/Naegle-Preferred_200x200-1-200x200.jpg\",\"contentUrl\":\"https:\\\/\\\/news.med.virginia.edu\\\/files\\\/2022\\\/10\\\/Naegle-Preferred_200x200-1-200x200.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/2022\\\/10\\\/26\\\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CPHG&#8217;s Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/#website\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/\",\"name\":\"Department of Genome Sciences\",\"description\":\"University of Virginia School of Medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/#\\\/schema\\\/person\\\/15282b0b67e8539d94e9d2e87eceacc9\",\"name\":\"jmd9fe@virginia.edu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c75f3daf5b7f0a0f103d04f8a162d27c626b6f438a96c33bdbe11614fb130646?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c75f3daf5b7f0a0f103d04f8a162d27c626b6f438a96c33bdbe11614fb130646?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c75f3daf5b7f0a0f103d04f8a162d27c626b6f438a96c33bdbe11614fb130646?s=96&d=mm&r=g\",\"caption\":\"jmd9fe@virginia.edu\"},\"url\":\"https:\\\/\\\/med.virginia.edu\\\/genome-sciences\\\/author\\\/jmd9fevirginia-edu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CPHG's Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments - Department of Genome Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/","og_locale":"en_US","og_type":"article","og_title":"CPHG's Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments - Department of Genome Sciences","og_description":"Kristen Naegle, PhD UVA Cancer Center researchers have developed an algorithm that will\u00a0improve cancer care\u00a0by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors. The algorithm may have other diagnostic benefits for patients as well. Kinase inhibitors are the most common cancer drugs approved by the federal Food and [&hellip;]","og_url":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/","og_site_name":"Department of Genome Sciences","article_published_time":"2022-10-26T16:16:20+00:00","article_modified_time":"2026-05-22T20:24:25+00:00","author":"jmd9fe@virginia.edu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jmd9fe@virginia.edu","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#article","isPartOf":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/"},"author":{"name":"jmd9fe@virginia.edu","@id":"https:\/\/med.virginia.edu\/genome-sciences\/#\/schema\/person\/15282b0b67e8539d94e9d2e87eceacc9"},"headline":"CPHG&#8217;s Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments","datePublished":"2022-10-26T16:16:20+00:00","dateModified":"2026-05-22T20:24:25+00:00","mainEntityOfPage":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/"},"wordCount":370,"commentCount":0,"image":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/news.med.virginia.edu\/files\/2022\/10\/Naegle-Preferred_200x200-1-200x200.jpg","keywords":["CPHG","Intranet","Kristen Naegle"],"articleSection":["Homepage Feed","People"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/","url":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/","name":"CPHG's Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments - Department of Genome Sciences","isPartOf":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/#website"},"primaryImageOfPage":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#primaryimage"},"image":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/news.med.virginia.edu\/files\/2022\/10\/Naegle-Preferred_200x200-1-200x200.jpg","datePublished":"2022-10-26T16:16:20+00:00","dateModified":"2026-05-22T20:24:25+00:00","author":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/#\/schema\/person\/15282b0b67e8539d94e9d2e87eceacc9"},"breadcrumb":{"@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#primaryimage","url":"https:\/\/news.med.virginia.edu\/files\/2022\/10\/Naegle-Preferred_200x200-1-200x200.jpg","contentUrl":"https:\/\/news.med.virginia.edu\/files\/2022\/10\/Naegle-Preferred_200x200-1-200x200.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/med.virginia.edu\/genome-sciences\/2022\/10\/26\/cphgs-kristen-naegle-phd-and-colleagues-develop-shining-kstar-to-guide-cancer-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.virginia.edu\/genome-sciences\/"},{"@type":"ListItem","position":2,"name":"CPHG&#8217;s Kristen Naegle, PhD and Colleagues Develop Shining \u2018KSTAR\u2019 to Guide Cancer Treatments"}]},{"@type":"WebSite","@id":"https:\/\/med.virginia.edu\/genome-sciences\/#website","url":"https:\/\/med.virginia.edu\/genome-sciences\/","name":"Department of Genome Sciences","description":"University of Virginia School of Medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.virginia.edu\/genome-sciences\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/med.virginia.edu\/genome-sciences\/#\/schema\/person\/15282b0b67e8539d94e9d2e87eceacc9","name":"jmd9fe@virginia.edu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c75f3daf5b7f0a0f103d04f8a162d27c626b6f438a96c33bdbe11614fb130646?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c75f3daf5b7f0a0f103d04f8a162d27c626b6f438a96c33bdbe11614fb130646?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c75f3daf5b7f0a0f103d04f8a162d27c626b6f438a96c33bdbe11614fb130646?s=96&d=mm&r=g","caption":"jmd9fe@virginia.edu"},"url":"https:\/\/med.virginia.edu\/genome-sciences\/author\/jmd9fevirginia-edu\/"}]}},"_links":{"self":[{"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/posts\/5018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/users\/1287"}],"replies":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/comments?post=5018"}],"version-history":[{"count":4,"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/posts\/5018\/revisions"}],"predecessor-version":[{"id":5033,"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/posts\/5018\/revisions\/5033"}],"wp:attachment":[{"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/media?parent=5018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/categories?post=5018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.virginia.edu\/genome-sciences\/wp-json\/wp\/v2\/tags?post=5018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}